Search
19 June 2013
  • Highlights Annual Press Conference 2013

    Watch the Video

  • #01

    perspectives for
    society

    In all our activities we safeguard our employees, facilities and the environment from harmful influences, conserve natural resources and promote environmental awareness.

    more

  • Key Aspects
    2012

    Play audio file

  • The Shareholders'
    Perspective

    Play audio file

  • Our company

    Boehringer Ingelheim is a research-driven company dedicated to researching and developing, manufacturing and marketing pharmaceuticals that improve health and quality of life. Our businesses are Human Pharmaceuticals and Animal Health. We focus on innovative drugs and treatments that represent major therapeutic advances. 

    more

  • #02

    perspectives
    for Medical Innovation

    Boehringer Ingelheim’s commitment to emerging science as a basis for new medicines grows ever stronger.

    more

  • Net sales
    2012

    Download Business
    Year 2012

    14.7

    +12 %

    bn. EUR

  • Group management
    Report 2012

    Download Group
    management report

  • #03

    PERSPECTIVES FOR
    BETTER HEALTH

    Boehringer Ingelheim drives progress in the form of medicines, technologies and solutions that help people.

    more

  • #04

    perspectives for
    quality in operations

    Operations at Boehringer Ingelheim ensure every day that patients can rely on receiving high quality medicines.

    more

  • Consolidated
    financial
    statement

    Download consolidated
    financial statements

  • Annual Report 2012
    on tablets

    Download for iPad, Android or Kindle

  • #05

    perspectives for
    established markets

    In contrast to emerging markets, mature markets are showing modest economic growth or stagnation. Their industry has to a
    great extent matured.

    more